14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $14.59 $16.67 Thursday, 25th Apr 2024 CPRX stock ended at $14.68. This is 2.91% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 2.91% from a day low at $14.59 to a day high of $15.01.
90 days $13.12 $17.50
52 weeks $11.09 $17.77

Historical Catalyst Pharmaceuticals prices

Date Open High Low Close Volume
Sep 20, 2023 $12.71 $12.74 $12.17 $12.18 781 003
Sep 19, 2023 $12.65 $12.83 $12.62 $12.71 642 277
Sep 18, 2023 $12.51 $12.84 $12.50 $12.62 1 066 803
Sep 15, 2023 $12.77 $12.82 $12.34 $12.46 4 410 606
Sep 14, 2023 $12.84 $12.96 $12.74 $12.81 838 781
Sep 13, 2023 $12.93 $13.09 $12.70 $12.73 1 167 448
Sep 12, 2023 $12.78 $13.07 $12.61 $12.93 971 846
Sep 11, 2023 $12.67 $12.92 $12.35 $12.78 1 309 542
Sep 08, 2023 $12.97 $12.99 $12.68 $12.74 1 152 502
Sep 07, 2023 $12.86 $13.15 $12.82 $12.92 1 592 529
Sep 06, 2023 $12.97 $13.19 $12.81 $12.90 1 265 699
Sep 05, 2023 $13.82 $13.87 $12.91 $12.94 1 564 298
Sep 01, 2023 $14.15 $14.21 $13.76 $13.92 883 856
Aug 31, 2023 $14.52 $14.52 $14.03 $14.04 967 516
Aug 30, 2023 $14.09 $14.48 $14.02 $14.44 905 055
Aug 29, 2023 $14.18 $14.29 $14.07 $14.11 714 841
Aug 28, 2023 $14.25 $14.33 $14.14 $14.21 531 692
Aug 25, 2023 $13.90 $14.32 $13.79 $14.24 927 443
Aug 24, 2023 $14.16 $14.13 $13.69 $13.85 1 139 399
Aug 23, 2023 $14.49 $14.53 $14.11 $14.14 921 220
Aug 22, 2023 $14.59 $14.60 $14.40 $14.42 601 081
Aug 21, 2023 $14.50 $14.72 $14.35 $14.60 849 323
Aug 18, 2023 $14.07 $14.52 $13.83 $14.44 1 084 598
Aug 17, 2023 $14.84 $14.97 $14.21 $14.24 1 170 081
Aug 16, 2023 $15.00 $15.24 $14.71 $14.74 1 241 070
Click to get the best stock tips daily for free!

About Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develop... CPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT